AZN vs CGEM · P/E 28, $288.38B cap vs $830.3M cap
AstraZeneca PLC (AZN) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the AZN and CGEM stock pages for the full models.
Not investment advice.